Cystitis treatment with high dose chondroitin sulfate
View Patent ↗Interstitial cystitis and related GAG-deficient conditions of the bladder and urinary tract are treated by instillation of high dose chondroitin sulfate, such as 400 mg/20 mL. The higher dose of chondroitin is effective for the rapid reduction of symptoms, particularly in patients with severe and otherwise recalcitrant cystitis.
1. A method of treating cystitis in a subject in need thereof, the method comprising:
treating the subject with a pharmaceutical composition comprising:
a unit dose of chondroitin sulfate in an amount of at least 350 mg, and
an aqueous vehicle in a volume of from 10 mL to 100 mL,
wherein the pharmaceutical composition is adapted for instillation to the bladder of the subject, so as to treat the cystitis in the subject.
2. The method according to claim 1 , wherein the chondroitin sulfate is present in an amount of 400 mg.
3. The method according to claim 1 , wherein the aqueous vehicle is present in an amount of 20 mL.
4. The method according to claim 1 , wherein the aqueous vehicle is phosphate-buffered saline.
5. The method according to claim 1 , wherein the cystitis is interstitial cystitis.
6. The method according to claim 1 , wherein treating cystitis with the pharmaceutical composition comprises:
providing a subject afflicted with cystitis or a related condition in which one or more cystitis symptoms are elicited in the subject afflicted upon instillation of a potassium chloride solution; and
instilling the pharmaceutical composition into the bladder or urinary tract of the subject.
7. The method according to claim 6 , wherein the instilling is performed at least once weekly for a period of at least 6 weeks.
8. The method according to claim 6 , wherein the instilling is performed at least twice weekly for a period of at least 6 weeks.
9. The method according to claim 1 , wherein the unit dose of chondroitin sulfate is at most equivalent to the solubility of chondroitin sulfate is said vehicle.
10. The method according to claim 1 , wherein the unit dose of chondroitin sulfate is less than or equal to 1200 mg.
11. The method according to claim 1 , wherein the unit dose of chondroitin sulfate is less than or equal to 800 mg.